Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study 2021-01-27 20:00
1